Biosimilars help to increase market competition. Balancing the use of biosimilars and biologics with strategic formulary decisions deliver lower costs. More
Effective management strategies can help payors manage cost for a range of new treatment options in the drug pipeline. Several medications are nearing approvals for Alzheimer’s, oncology... More
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More